PULMONARY HYPERTENSION

摘要

The disclosure relates to agents that inhibit the activity of Tumour Necrosis Factor Apoptosis-Inducing Ligand [TRAIL] and their use in the treatment of pulmonary hypertension.

主权项

1. A method of treating pulmonary hypertension, comprising:
administering to a subject having pulmonary hypertension an effective amount of an agent that inhibits expression of TRAIL or TRAIL protein activity, thereby treating the pulmonary hypertension.